These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 23214288)

  • 1. The role of human papillomavirus in the malignant transformation of cervix epithelial cells and the importance of vaccination against this virus.
    Ciesielska U; Nowińska K; Podhorska-Okołów M; Dziegiel P
    Adv Clin Exp Med; 2012; 21(2):235-44. PubMed ID: 23214288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of type-specific human papillomavirus infection among women in France: Implications for screening, vaccination, and a future generation of multivalent HPV vaccines.
    Monsonego J; Zerat L; Syrjänen K; Zerat JC; Smith JS; Halfon P
    Vaccine; 2012 Jul; 30(35):5215-21. PubMed ID: 22713720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human papillomavirus type-distribution in the cervix of Chinese women: a meta-analysis.
    Bao YP; Li N; Smith JS; Qiao YL
    Int J STD AIDS; 2008 Feb; 19(2):106-11. PubMed ID: 18334063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human Pappilomavirus (HPV) induced cancers and prevention by immunization.
    Khaliq SA; Shyum Naqvi SB; Fatima A
    Pak J Pharm Sci; 2012 Oct; 25(4):763-72. PubMed ID: 23009992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [HPV and cervical cancer].
    J Midwifery Womens Health; 2013; 58(2):245-6. PubMed ID: 23451858
    [No Abstract]   [Full Text] [Related]  

  • 6. Human papilloma virus (HPV) prophylactic vaccination: challenges for public health and implications for screening.
    Adams M; Jasani B; Fiander A
    Vaccine; 2007 Apr; 25(16):3007-13. PubMed ID: 17292517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevalence of human papilloma virus isolated from cervix lesions in a female population from Transilvania].
    Feticu L; Bocşan IS; Bondor Cl; Boboş C
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(2):567-74. PubMed ID: 23077955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HPV genotypes: implications for worldwide cervical cancer screening and vaccination.
    Wheeler CM
    Lancet Oncol; 2010 Nov; 11(11):1013-4. PubMed ID: 20952255
    [No Abstract]   [Full Text] [Related]  

  • 9. Regulation of immune responses to HPV infection and during HPV-directed immunotherapy.
    Bhat P; Mattarollo SR; Gosmann C; Frazer IH; Leggatt GR
    Immunol Rev; 2011 Jan; 239(1):85-98. PubMed ID: 21198666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of human papilloma virus-induced preneoplasia and cancer by prophylactic HPV vaccines.
    Hampl M
    Minerva Med; 2007 Apr; 98(2):121-30. PubMed ID: 17519854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [PAPILLOMAVIRUS INFECTION: PRINCIPLE CHARACTERISTICS, CLINICAL MANIFESTATIONS, VACCINE PROPHYLAXIS].
    Lopukhov PD; Briko NI; Khaldin AA; Tsapkova NN; Lupashko OV
    Zh Mikrobiol Epidemiol Immunobiol; 2016; (1):71-8. PubMed ID: 27029121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategies against human papillomavirus infection and cervical cancer.
    Jung WW; Chun T; Sul D; Hwang KW; Kang HS; Lee DJ; Han IK
    J Microbiol; 2004 Dec; 42(4):255-66. PubMed ID: 15650698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [How technology and vaccination have changed the Pap test].
    Bondi A; Ghidoni D; Amadori A
    Pathologica; 1999 Feb; 91(1):36-41. PubMed ID: 10396949
    [No Abstract]   [Full Text] [Related]  

  • 14. [Vaccination against human papillomavirus for the prevention of cervical cancer].
    Quint WG; ter Harmsel WA; van Doorn LJ
    Ned Tijdschr Geneeskd; 2006 Jun; 150(25):1380-4. PubMed ID: 16841585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of cross-protection against oncogenic HPV by an HPV-16/18 AS04-adjuvanted cervical cancer vaccine: importance of virological and clinical endpoints and implications for mass vaccination in cervical cancer prevention.
    Jenkins D
    Gynecol Oncol; 2008 Sep; 110(3 Suppl 1):S18-25. PubMed ID: 18653221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variation in genital human papillomavirus infection prevalence and vaccination coverage among men and women in the USA.
    Han JJ; Tarney CM; Song J
    Future Oncol; 2017 Jun; 13(13):1129-1132. PubMed ID: 28589730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human papilloma viruses and cancer in the post-vaccine era.
    Galani E; Christodoulou C
    Clin Microbiol Infect; 2009 Nov; 15(11):977-81. PubMed ID: 19874381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human papillomaviruses and cervical cancer.
    DiMaio D; Liao JB
    Adv Virus Res; 2006; 66():125-59. PubMed ID: 16877060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two HPV vaccines yielding similar success.
    Washam C
    J Natl Cancer Inst; 2005 Jul; 97(14):1030. PubMed ID: 16030297
    [No Abstract]   [Full Text] [Related]  

  • 20. [Cervical carcinoma and the vaccination experience with Cervarix].
    Berberova M
    Akush Ginekol (Sofiia); 2012; 51 Suppl 1():4-5. PubMed ID: 23236670
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.